Navigation Links
Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Date:9/9/2009

THE WOODLANDS, Texas, Sept. 9 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that Arthur T. Sands, M.D., Ph.D., Lexicon's president and chief executive officer, will present at the Morgan Stanley Global Healthcare Unplugged Conference at the Grand Hyatt hotel in New York, New York on Tuesday, September 15, 2009 at 1:35 p.m. Eastern Time.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease. Lexicon currently has five drug candidates in development for autoimmune disease, carcinoid syndrome, diabetes, glaucoma and irritable bowel syndrome, all of which were discovered by the company's research team. The company has used its proprietary gene knockout technology to identify more than 100 promising drug targets. Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs. For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other ma
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28, 2009
2. Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome
3. Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer
4. Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
5. Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2009 Financial Results on April 28, 2009
6. Lexicon Pharmaceuticals 2008 Annual Report to Stockholders Available Online
7. Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
8. Lexicon to Report Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
9. Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome
10. Lexicon Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
11. Lexicon Pharmaceuticals to Present at the Piper Jaffray 19th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... CA (PRWEB) October 02, 2014 ... high throughput research solutions for biopharmaceutical development, today ... 23 - 24, 2014 at GlaxoSmithKline (GSK) in ... and discussions of best practices in high throughput ... Summit, R&D leaders gathered together to discuss the ...
(Date:10/2/2014)... At a time when many are feeling their ... a new kind of squeeze aimed at containing lab costs ... Squeeze Riteā„¢ Wash Bottle , catalog no. F11717-0030. Innovative in ... reduces the waste of reagents, solutions and other liquids by ... to squeeze when compared to standard 500ml bottles, its unique ...
(Date:10/2/2014)... SIRO Clinpharm, an award-winning Clinical ... prestigious Annual Conference of the Society for Clinical Data ... , where they were invited to speak at three ... analytics to support fraud detection, ,clinical data management,s role ... working together as virtual and integrated teams,. The award-winning ...
(Date:10/1/2014)... 2014 Weighing applications in pharmaceutical ... final product. However, while the pharmaceutical industry is ... as Good Manufacturing Practices (GMP) usually provide only ... manufacturer to interpret these guidelines and assess process ... METTLER TOLEDO experts have created a new white ...
Breaking Biology Technology:Freeslate European Summit Highlights Best Practices in High Throughput Research and Data Management 2New Wash Bottle Reduces Waste of Reagents, Solutions, and Other Liquids 2SIRO Clinpharm Showcases Biometrics Capabilities at the SCDM 2014 Annual Conference in Las Vegas 2Comply with Weighing-Related Regulations in Pharma Manufacturing 2
... first time, researchers at North Carolina State University ... are physically or chemically different so-called Janus ... an alternating electrical field is applied to liquid ... research, published in the Feb. 8, 2008, edition ...
... Pharmaceuticals,Inc. (Nasdaq: ARNA ) today reported financial results ... 2007., Total revenues in the fourth quarter of ... fourth quarter of 2006. Total revenues in,the full year ... $30.6,million in the full year ended December 31, 2006, ...
... /PRNewswire/ -. Mr. Richard W.,Decker II will be ... Biological Center (ECBC) March 2. He has served ... of Engineering within the,organization since February 2005., ... 1,600 Department,of the Army civilians, soldiers and on-site ...
Cached Biology Technology:'2-faced' particles act like tiny submarines 2Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 2Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 3Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 4Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 5Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 6Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 7Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 8Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 9Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 10Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results 11Mr. Richard Decker Appointed Technical Director of Edgewood Chemical Biological Center 2
(Date:10/1/2014)... Scientists have discovered a new form of non-genetic inheritance, ... a mother,s previous sexual partner in flies at ... to ancient Greek times, but was discredited in the ... test it out, UNSW Australia scientists Dr Angela Crean, ... size of male flies and studied their offspring., They ...
(Date:9/30/2014)... Millions of tourists visit the Mediterranean each year, ... currently underway on Earth. Almost 1,000 alien species, ... from other seas through human activities. In the ... a multinational team of researchers analyzed data from ... Commission to show how the introduction of alien ...
(Date:9/30/2014)... all have in common? Unlike most eukaryotic multicellular ... diploid, these organisms are all polyploid, meaning they have ... have 3 and 4 sets of chromosomes, respectively, and ... in fact most plant species are polyploid. Polyploidy, or ... but only recently, with the development of molecular tools, ...
Breaking Biology News(10 mins):Semen secrets: How a previous sexual partner can influence another male's offspring 2Biodiversity in the Mediterranean is threatened by alien species 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 2Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 3Gene doubling shapes the world: Instant speciation, biodiversity, and the root of our existence 4
... popularity of garlic as a food ingredient and its ... the distinctive pungency associated with its raw, uncooked state. ... a characteristic mixture of burning and prickling sensations and ... a particular compound and its ability to activate specific ...
... nonprofit pharmaceutical company in the U.S., announced today it ... regulatory agencies in the world, the Food and Drug ... of Medicinal Products (EMEA), for paromomycin to treat visceral ... ("black fever"), is a fatal disease transmitted by sand ...
... complaint against British drug maker GlaxoSmithKline (GSK) over its ... proceed following an order late last week by South ... go forward. GSK has sought outright dismissal of the ... week giving the complainants, AIDS Healthcare Foundation (AHF) and ...
Cached Biology News:Activation of thermoreceptors mediates raw garlic's burning pungency 2OneWorld Health drug receives 'Orphan' designation from U.S. and European regulatory agencies 2South African Tribunal Asks For Damages Estimates in GSK AIDS Drug Case 2
Lingo-1 (K-13)...
... well-characterized tissue-specific stem cells that exhibit remarkable ... life-long maintenance of the hematopoietic system. HSC ... bone marrow where hematopoiesis is continuously taking ... cord blood, fetal liver, adult spleen and ...
Human DEP-1/CD148 Fluorescein MAb (Clone 143-41) Protein Family: Granulocyte Markers, Monocyte Markers, Phosphatases & Regulators, Other Dendritic Cell Molecules...
MOUSE ANTI PORCINE SLA 1:FITC Immunogen: Porcine peripheral blood mononuclear cells....
Biology Products: